Back to Test Catalogue

Everolimus (LC-MS/MS), Blood

Test ID: EVERO WB

Test

Method

Chromatography/Mass Spectrometry

Report Includes

Everolimus

Specimens

Whole blood (EDTA)

Test Location

Quest Diagnostics, Virginia USA

Test Version

17-Mar-2023

Specimen

Specimens

Whole blood (EDTA)

Collection Containers

Lavender top (EDTA)

Sample Volume

2 mL

Minimum Volume

1 mL

Collection & Handling

Handling Information

Drug regimens are to be noted on requisition: Time and date of drug administration.Therapeutic range applies to trough specimens drawn just prior to a.m. dose.

Stability

Ambient 7 days
Refrigerated 14 days
Frozen 30 days

Additional Stability Information

Store and send cold or frozen.

Rejection Criteria

Specimen Gel-separator tube or Clotted specimens

Test Version

17-Mar-2023

Performance / Interpretation

Method

Chromatography/Mass Spectrometry

Turnaround Time

11 days

Results

Name Units Reference Range Conversion Factor
Everolimus, LC/MS/MS, Blood ng/mL
  • Trough 3.0 - 8.0 for Transplantation
  • Trough 5.0 - 10.0 for Oncology/Neurology
Symptoms of toxicity are more likely to occur at trough levels exceeding 12.0 ng/mL

Test Location

Quest Diagnostics, Virginia USA

Test Version

17-Mar-2023

Interface / Setup

HL7 Interface Codes

Order Code Result Codes Units
EVERO WB 63548EVEROLIMUS,LC/MS/MS,BLOOD ng/mL

Test Version

17-Mar-2023